Targeting the potent immunosuppressive properties of FOXP3 ⁺ regulatory T cells (T _regs ) has substantial therapeutic potential for treating autoimmune and inflammatory diseases. Yet, the molecular mechanisms controlling T _reg homeostasis, particularly during inflammation, remain unclear. We report that caspase-8 is a central regulator of T _reg homeostasis in a context-specific manner that is decisive during immune responses. In mouse genetic models, targeting caspase-8 in T _regs led to accumulation of effector T _regs resistant to apoptotic cell death. Conversely, inflammation induced the MLKL-dependent necroptosis of caspase-8–deficient lymphoid and tissue T _regs , which enhanced immunity to a variety of chronic infections to promote clearance of viral or parasitic pathogens. However, improved immunity came at the risk of lethal inflammation in overwhelming infections. Caspase-8 inhibition using a clinical-stage compound revealed that human T _regs have heightened sensitivity to necroptosis compared with conventional T cells. These findings reveal a fundamental mechanism in T _regs that could be targeted to manipulate the balance between immune tolerance versus response for therapeutic benefit.